Log in to save to my catalogue

New Pharmacological Strategies against Pancreatic Adenocarcinoma: The Multifunctional Thiosemicarbaz...

New Pharmacological Strategies against Pancreatic Adenocarcinoma: The Multifunctional Thiosemicarbaz...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_77d58d0d3450434baa4df90017374e7e

New Pharmacological Strategies against Pancreatic Adenocarcinoma: The Multifunctional Thiosemicarbazone FA4

About this item

Full title

New Pharmacological Strategies against Pancreatic Adenocarcinoma: The Multifunctional Thiosemicarbazone FA4

Publisher

Switzerland: MDPI AG

Journal title

Molecules (Basel, Switzerland), 2022-03, Vol.27 (5), p.1682

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

A new sigma-2 (σ2) receptor ligand (FA4) was efficiently synthesized and evaluated for cytotoxic, proapoptotic, and antimigratory activity on pancreatic ductal adenocarcinoma (PDAC) primary cell cultures, which restrained the aggressive and chemoresistant behavior of PDAC. This compound showed relevant antiproliferative activity with half maximal i...

Alternative Titles

Full title

New Pharmacological Strategies against Pancreatic Adenocarcinoma: The Multifunctional Thiosemicarbazone FA4

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_77d58d0d3450434baa4df90017374e7e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_77d58d0d3450434baa4df90017374e7e

Other Identifiers

ISSN

1420-3049

E-ISSN

1420-3049

DOI

10.3390/molecules27051682

How to access this item